Drug Markets/Sucroferric Oxyhydroxide

Sucroferric Oxyhydroxide

1 NDC across 1 manufacturer|0 Generic,1 Brand

Sucroferric Oxyhydroxide is used to treat hyperphosphatemia, per the National Library of Medicine's MED-RT classification.

▸ More about this market

In 2024, Medicare Part D spent $438 million on Sucroferric Oxyhydroxide across 157,000 claims for 38,000 beneficiaries.

Sucroferric Oxyhydroxide is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $17.11 to $17.11 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$17.11 – $17.11

per EA

7d Activity

1 flat

avg +0.0% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing SUCROFERRIC OXYHYDROXIDE

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
VELPHORO 500 MG CHEWABLE TAB
$17.1055
per EA
—

Frequently Asked Questions

What is Sucroferric Oxyhydroxide used to treat?

Sucroferric Oxyhydroxide is used to treat hyperphosphatemia, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Sucroferric Oxyhydroxide?

In 2024, Medicare Part D spent $438 million on Sucroferric Oxyhydroxide across 157,000 claims for 38,000 beneficiaries.

How many Sucroferric Oxyhydroxide products are on the market?

The Sucroferric Oxyhydroxide drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Sucroferric Oxyhydroxide?

NADAC reference prices for Sucroferric Oxyhydroxide range from $17.1055 to $17.1055 per EA.

Which manufacturers make Sucroferric Oxyhydroxide?

1 manufacturer lists Sucroferric Oxyhydroxide in NADAC. Ranked by number of NDCs, the largest are Fresenius Medical Care Renal Therapies Group, LLC (1).